BLOG / 🇮🇳 India / index intelligence · · daily

BSE Sensex 30 Stocks Regulatory Filings — July 31, 2026

India BSE SENSEX 30

By Gunpowder Editorial ·

8 high priority 23 medium priority 31 total filings analysed

Executive Summary

The 31 filings from SENSEX 30 constituents reveal a mixed earnings season: while revenue growth remains robust across most companies, profitability is under pressure from cost inflation, regulatory changes, and geopolitical disruptions.

Notable trends include margin compression in auto (Maruti Suzuki) and cigarettes (ITC) due to input cost and excise duty hikes, while financials like Bajaj Finance and Axis Bank show strong growth and improving asset quality. Insider activity is limited, but board changes and capital allocation moves (ESOP issues, re-insurance foray) signal strategic shifts. Forward-looking catalysts include L&T's six-year EPC framework with PDO, Sun Pharma's Organon acquisition, and Maruti's CBG projects. Key risks include Bajaj Finserv's insurance subsidiaries' profit declines, ITC's regulatory hit, and Sun Pharma's US generics pricing pressure. Overall, the digest highlights selective opportunities in financials and pharma, while caution is advised for auto and cigarette segments.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Company update · Board meeting · Corporate governance

Tracking the trend? Catch up on the prior BSE Sensex 30 Stocks Regulatory Filings digest from July 30, 2026.

Investment Signals (12)

  • PAT grew 27.4% YoY to ₹5,986 Cr, driven by lower loan losses and 23.9% AUM expansion; gross NPA improved to 0.96% from 1.03% YoY

  • Consolidated net profit up 27.0% YoY to ₹28,947.9M, with exceptional items down from ₹8,180M to ₹2,040.9M; Innovative Medicines now larger than generics in US

  • Axis Bank (BULLISH)

    All 18 AGM resolutions passed with overwhelming support; authorized ₹35,000 Cr debt and ₹20,000 Cr equity raising, indicating growth appetite

  • L&T (BULLISH)

    Subsidiary signed six-year EPC framework with PDO, selected as one of four contractors; reinforces long-term partnership and ICV development

  • Received additional orders worth ₹847 Cr since July 13, 2026, spanning electro optics, seekers, and services

  • ITC FMCG-Others (BULLISH)

    Segment revenue grew 12.0% YoY, EBITDA up 15.9% YoY; Fresh Food GMV grew 90% YoY, ARR crossed ₹300 Cr

  • Net sales surged 36% YoY, market share gained 2.3 ppts to 41.2%; but PAT declined 10.8% YoY due to material costs

  • Consolidated revenue up 19.1% YoY, but PAT attributable to owners grew only 12.3%; insurance subsidiaries' PAT declined sharply

  • ITC Cigarettes (BEARISH)

    Segment profit fell 35.1% YoY due to excise duty hike; company implemented 30+ interventions to re-architect portfolio

  • US generics business faces pricing and compliance pressures; R&D expenses down 8.6% YoY

  • Bajaj General Insurance (BEARISH)

    PAT fell 27.6% YoY; combined ratio worsened to 104.7% from 103.6%

  • Bajaj Life Insurance (MIXED)

    PAT dropped 70.2% YoY to ₹51 Cr, despite 35% rise in GWP; VNB surged 87%

Risk Flags (8)

  • ITC/Regulatory [HIGH RISK]

    Excise duty on cigarettes jumped 666% YoY, compressing margins; PAT down 27.1% YoY

  • Material cost ratio rose 600 bps YoY to 80.5% of net sales; operating EBITDA down 6.7% YoY

  • Insurance subsidiaries' PAT declined sharply (General -27.6%, Life -70.2%); adjusted PAT growth only 5%

  • Pricing and compliance pressures in US generics; R&D spend down 8.6% YoY may impact pipeline

  • Bajaj General/Underwriting [MEDIUM RISK]

    Combined ratio worsened to 104.7% from 103.6%; underwriting loss increased to ₹130 Cr

  • ITC/Consolidated [MEDIUM RISK]

    Consolidated PAT down 15.6% YoY; EPS down 16.2%

  • Operating EBITDA dropped 30.0% QoQ due to higher material costs and seasonal expenses

  • Issued 1.51M shares to ESOP trust, aggregating ₹196.08 Cr, potentially diluting EPS

Opportunities (9)

  • Gross NPA improved to 0.96% from 1.03% YoY; strong AUM growth of 23.9% indicates robust demand

  • Proposed acquisition of Organon & Co. is largest in history; expected to transform portfolio

  • L&T/PDO Framework (OPPORTUNITY)

    Six-year EPC framework with PDO provides revenue visibility; one of four contractors for FEED and EPC projects

  • ITC/FMCG-Others (OPPORTUNITY)

    Segment revenue up 12.0% YoY, EBITDA up 15.9%; Fresh Food GMV up 90% YoY, ARR crossed ₹300 Cr

  • Board approved 4 CBG projects with ₹5,610 million budget; expansion planned based on experience

  • Board approved pursuing re-insurance business through new subsidiary, subject to IRDAI approval

  • Authorized ₹20,000 Cr equity raising, indicating growth plans; all resolutions passed with minimal opposition

  • Additional orders of ₹847 Cr since July 13, 2026; strong defense spending environment

  • Innovative Medicines now larger than generics in US; shift to higher-margin products

Sector Themes (6)

  • Margin Compression in Autos

    Maruti Suzuki's material costs rose 600 bps YoY, leading to PAT decline despite 36% revenue growth; input cost inflation is a sector-wide concern [IMPLICATION: Watch for pricing power and cost pass-through]

  • Regulatory Impact on Cigarettes

    ITC's excise duty hike (666% YoY) crushed cigarette margins; similar regulatory risks may affect other sin sectors [IMPLICATION: Regulatory changes can drastically alter profitability]

  • Financials Outperformance

    Bajaj Finance and Axis Bank show strong growth and improving asset quality; financials are outperforming other sectors in the index [IMPLICATION: Favor financials in portfolio allocation]

  • Pharma Shift to Innovation

    Sun Pharma's Innovative Medicines now larger than generics in US; R&D investment is key to sustaining growth [IMPLICATION: Companies with strong pipelines will outperform]

  • Infrastructure and Defense Orders

    L&T and BEL secured significant orders, indicating robust demand in infrastructure and defense [IMPLICATION: Positive for capital goods and defense sectors]

  • Board Succession and Governance

    Multiple board changes (HCL, SBI, Bajaj Finserv, etc.) but no adverse auditor remarks; governance remains stable [IMPLICATION: Management continuity is a positive signal]

Watch List (8)

Filing Analyses (31)
Bajaj Finserv Limited Market Notice mixed materiality 9/10

31-07-2026

Bajaj Finserv reported consolidated revenue of ₹42,037 Cr for Q1 FY2027, up 19.1% YoY, and consolidated PAT of ₹6,297 Cr, up 18.2% YoY. However, PAT attributable to owners grew only 12.3% to ₹3,132 Cr, and excluding mark-to-market gains, growth was just 5%. The insurance subsidiaries saw sharp PAT declines: Bajaj General PAT fell 27.6% to ₹478 Cr due to lower capital gains and higher loss ratios, while Bajaj Life PAT dropped 70.2% to ₹51 Cr. In contrast, Bajaj Finance delivered strong PAT growth of 27.4% to ₹5,986 Cr, driven by lower loan losses and robust AUM expansion of 23.9%.

  • · Bajaj General's solvency margin stood at 254% vs regulatory norm of 150%.
  • · Bajaj Life's solvency remained healthy at 285%.
  • · Bajaj Housing Finance's capital adequacy ratio was 21.59% vs regulatory requirement of 15.0% (Tier-1 capital 21.17%).
  • · Bajaj Finance's annualized loan losses to average AUF improved from 1.87% in Q1 FY2026 to 1.54% in Q1 FY2027.
  • · Bajaj AMC ranked 26th amongst all Mutual Funds with equity mix at 63% and non-group share at 90.9% of total AUM.
  • · Bajaj AMC SIP folios grew 69% YoY.
  • · Bajaj Financial Securities retail and HNI customer franchise grew 41.1% YoY to 14.9 Lakh.
  • · Group market capitalisation stood at ₹1,160,000+ Cr as of 27 July 2026.
  • · Group consolidated AUM was ₹750,000+ Cr as of 30 June 2026.
  • · Group consolidated revenue for FY2026 was ₹150,500+ Cr and consolidated PAT was ₹9,800+ Cr.
  • · Bajaj General's ROE (annualized @200% solvency) estimated at ~17.3%.
  • · Bajaj Life's retail protection grew 60% with 12% product mix.
  • · Bajaj Life renewal growth continued at 18% for Q1 FY2027.
  • · Bajaj Finance booked 1.61 crore new loans in Q1 FY2027 vs 1.35 crore in Q1 FY2026, growth of 20%.
  • · Bajaj Finance added 51 lakh new customers during the quarter.
  • · Bajaj Finserv Direct revenue back on growth trajectory after planned digital customer journey enhancements.
  • · Bajaj Finserv Health had muted revenue growth due to planned business model realignment.
  • · Bajaj AMC SIP book grew 66% YoY to ₹189 Crore as of June 2026.
  • · Bajaj Financial Securities AUM grew 60.2% YoY to ₹9,770 Cr.
  • · AI initiatives realized impact: loan disbursements ₹2,500+ Crore; insurance subsidiaries revenue ₹60+ Crore in Q1 FY2027.
Sun Pharmaceutical Industries Limited Market Update positive materiality 9/10

31-07-2026

Sun Pharmaceutical Industries reported consolidated revenue from operations of ₹152,998.8 million for Q1 FY27, up 10.5% YoY from ₹138,514.0 million in Q1 FY26. Net profit after taxes and non-controlling interests rose 27.0% YoY to ₹28,947.9 million, driven by strong operational performance and lower exceptional charges. However, standalone revenue grew only 2.6% YoY to ₹57,411.3 million, while standalone net profit surged 49.7% YoY to ₹11,151.4 million, partly aided by a sharp reduction in exceptional items.

  • · Consolidated exceptional items for Q1 FY27 were ₹2,040.9 million, down from ₹8,180.0 million in Q1 FY26.
  • · Standalone exceptional items for Q1 FY27 were ₹315.3 million, down from ₹2,876.4 million in Q1 FY26.
  • · Consolidated R&D expenses for Q1 FY27 were ₹8,076.6 million, down 8.6% YoY from ₹8,841.0 million.
  • · Standalone R&D expenses for Q1 FY27 were ₹4,635.9 million, down 24.6% YoY from ₹6,146.9 million.
  • · Consolidated other comprehensive income (OCI) was ₹15,091.5 million in Q1 FY27 versus ₹1,274.2 million in Q1 FY26.
  • · Standalone OCI was ₹1,443.3 million in Q1 FY27 versus ₹196.8 million in Q1 FY26.
  • · Consolidated finance costs rose 33.2% YoY to ₹996.7 million from ₹748.0 million.
  • · Standalone finance costs rose 16.8% YoY to ₹2,784.8 million from ₹2,384.2 million.
Trent Limited Market Update neutral materiality 1/10

31-07-2026

Trent Limited has sent a letter to identified shareholders urging them to claim unclaimed dividends before the amounts are transferred to the Investor Education and Protection Fund (IEPF). The letter details the process for claiming dividends for various years, with deadlines ranging from August 2026 to July 2032. This is a routine regulatory compliance intimation under Regulation 30 of SEBI (LODR) Regulations, 2015, and does not contain any financial performance data or material business developments.

  • · Shareholders must claim dividends by specific deadlines ranging from 17-Aug-2026 to 19-Jul-2032 depending on the dividend payment date.
  • · Unclaimed dividends will be transferred to the IEPF after seven years from the date of transfer to the unpaid dividend account.
  • · Shareholders can claim transferred dividends from IEPF by submitting an online application in Form IEPF-5 on www.iepf.gov.in.
  • · The company's Registrar and Transfer Agent is MUFG Intime India Private Limited.
Bharti Airtel Limited Company Update neutral materiality 1/10

31-07-2026

Bharti Airtel disclosed receipt of a financial disincentive order from TRAI for INR 6,30,000 (Rupees Six Lakh Thirty Thousand only) for alleged non-compliance of the Telecommunication Mobile Number Portability Regulations, 2009. The company has opted not to contest and will pay the penalty. The financial impact is minimal relative to Airtel's scale.

  • · Order received on July 30, 2026 at 1621 Hrs IST.
  • · Alleged non-compliance relates to Telecommunication Mobile Number Portability Regulations, 2009.
  • · Company has opted not to contest and will pay the financial disincentive.
ITC Limited Result mixed materiality 9/10

31-07-2026

ITC Limited reported a mixed set of results for Q1 FY27 (quarter ended June 30, 2026). On a standalone basis, revenue from operations grew 27.9% YoY to ₹26,943.23 Cr, driven by a sharp increase in excise duty on cigarettes following the expiry of GST compensation cess. However, profit before tax declined 27.3% YoY to ₹4,759.41 Cr, and profit after tax fell 27.1% YoY to ₹3,578.82 Cr, as the excise duty hike significantly compressed margins. The FMCG-Cigarettes segment, the largest profit contributor, saw its segment result drop 35.1% YoY to ₹3,341.23 Cr. On a positive note, the FMCG-Others segment (branded packaged foods, personal care) continued to grow, with segment revenue up 12.0% YoY and EBITDA rising 15.9% YoY to ~₹631.06 Cr. The company also completed the acquisition of Sproutlife Foods Private Limited as a subsidiary and increased its stake in Mother Sparsh Baby Care Private Limited to 49.32%.

  • · Standalone excise duty jumped to ₹10,035.63 Cr in Q1 FY27 from ₹1,309.07 Cr in Q1 FY26, a 666% increase, due to the GST compensation cess expiry and government duty hike.
  • · Standalone FMCG-Cigarettes segment revenue rose 80.6% YoY to ₹15,383.55 Cr, but segment profit fell 35.1% YoY to ₹3,341.23 Cr, reflecting the excise duty impact.
  • · Standalone FMCG-Others segment revenue grew 12.0% YoY to ₹6,481.95 Cr, with EBITDA of ~₹631.06 Cr (up 15.9% YoY).
  • · Standalone Agri Business segment revenue declined 16.6% YoY to ₹8,082.06 Cr, and segment profit fell 18.4% YoY to ₹353.79 Cr.
  • · Standalone Paperboards, Paper & Packaging segment revenue grew 9.0% YoY to ₹2,307.24 Cr, and segment profit rose 37.9% YoY to ₹224.22 Cr.
  • · The company acquired Sproutlife Foods Private Limited as a subsidiary effective April 1, 2026, and recognized a ₹405.88 Cr exceptional gain on re-measurement of its existing interest.
  • · On May 19, 2026, ITC acquired additional shares in Mother Sparsh Baby Care Private Limited, increasing its stake to 49.32%.
  • · Consolidated basic EPS fell to ₹3.51 from ₹4.19 in the prior year quarter.
  • · The auditors issued an unmodified (clean) review report on both standalone and consolidated results.
ITC Limited Board Meeting mixed materiality 9/10

31-07-2026

ITC Limited reported standalone revenue from operations of ₹26943.23 Cr for Q1 FY26 (quarter ended June 30, 2026), up 27.9% YoY from ₹21069.81 Cr in Q1 FY25, driven by a sharp increase in excise duty on cigarettes. However, standalone profit before tax declined 27.3% YoY to ₹4759.41 Cr from ₹6543.48 Cr, and profit after tax fell 27.1% to ₹3578.82 Cr from ₹4910.73 Cr, reflecting higher excise costs and brand-building expenses. Consolidated revenue rose 27.6% YoY to ₹29523.30 Cr, but consolidated profit after tax dropped 15.6% to ₹4508.79 Cr from ₹5343.41 Cr. The FMCG-Cigarettes segment saw revenue surge 80.6% YoY to ₹15383.55 Cr, yet its segment profit declined 35.1% to ₹3341.23 Cr, while FMCG-Others revenue grew 12.0% and segment profit rose 20.9%.

  • · Standalone basic EPS fell to ₹2.86 from ₹3.93 YoY, a 27.2% decline.
  • · Consolidated basic EPS fell to ₹3.51 from ₹4.19 YoY, a 16.2% decline.
  • · Standalone other income was ₹645.33 Cr vs ₹662.03 Cr YoY, down 2.5%.
  • · Consolidated other income was ₹655.71 Cr vs ₹682.21 Cr YoY, down 3.9%.
  • · Standalone finance costs more than doubled to ₹33.78 Cr from ₹13.40 Cr YoY.
  • · Consolidated finance costs rose to ₹39.78 Cr from ₹16.47 Cr YoY, up 141.5%.
  • · Standalone total expenses increased 50.3% YoY to ₹22829.15 Cr from ₹15188.36 Cr, largely due to excise duty jumping to ₹10035.63 Cr from ₹1309.07 Cr.
  • · Consolidated total expenses increased 48.1% YoY to ₹24809.95 Cr from ₹16752.31 Cr.
  • · Standalone segment assets for FMCG-Others rose to ₹17108.07 Cr from ₹16496.41 Cr YoY.
  • · Standalone segment liabilities for FMCG-Cigarettes rose to ₹9771.49 Cr from ₹5975.77 Cr YoY.
  • · The company acquired 1,681 equity shares of Mother Sparsh Baby Care Private Limited on 19 May 2026, increasing stake to 49.32%.
  • · Sproutlife Foods Private Limited became a subsidiary effective 1 April 2026.
  • · The Board meeting commenced at 12:55 p.m. and concluded at 2:30 p.m. (time partially redacted).
Maruti Suzuki India Limited Result mixed materiality 8/10

31-07-2026

Maruti Suzuki India Limited reported standalone revenue from operations of ₹524,557 million for Q1 FY27 (quarter ended June 30, 2026), up 35.9% YoY from ₹385,930 million in Q1 FY26. However, standalone profit after tax (PAT) declined 10.8% YoY to ₹33,521 million from ₹37,581 million, and EPS (basic) fell to ₹106.62 from ₹119.53. Consolidated results mirrored the standalone trend: revenue grew 35.9% YoY to ₹524,698 million, while PAT declined 9.1% YoY to ₹34,469 million and EPS (basic) dropped to ₹109.63 from ₹120.62.

  • · Standalone other income fell to ₹18,737 million in Q1 FY27 from ₹18,879 million in Q1 FY26, a marginal decline of 0.8%.
  • · Standalone total expenses rose 40.5% YoY to ₹499,881 million, outpacing revenue growth.
  • · Standalone cost of materials consumed increased 45.9% YoY to ₹320,132 million.
  • · Standalone employee benefits expense grew 20.3% YoY to ₹24,569 million.
  • · Standalone depreciation and amortisation rose 14.4% YoY to ₹17,800 million.
  • · Standalone finance costs increased 35.7% YoY to ₹635 million.
  • · Consolidated share of profit of associates jumped to ₹891 million from ₹296 million YoY, a 201% increase.
  • · Consolidated share of profit of joint ventures rose to ₹86 million from ₹59 million YoY, a 45.8% increase.
  • · Standalone EPS (basic) for the full year ended March 31, 2026 was ₹459.46; consolidated was ₹466.90.
ITC Limited Company Update mixed materiality 9/10

31-07-2026

ITC Limited reported its Q1 FY27 (June 30, 2026) results, with standalone gross revenue up 28% YoY, but net revenue down 14% YoY (ex-Agri -6% YoY) and EBITDA and PAT declining 28% and 27% YoY respectively, reflecting the impact of the West Asia conflict and an unprecedented tax increase on cigarettes. The FMCG segment (ex-Staples) grew 16% YoY and segment PBIT rose 21% YoY, while the Paper segment PBIT surged 38% YoY. However, the Agri Business segment saw underlying revenue growth of only 9% YoY after adjusting for disruptions, and the Cigarettes Business faced a strategic response to a major tax hike with over 30 interventions implemented.

  • · The Cigarettes Business implemented over 30 interventions to re-architect the product portfolio in response to an unprecedented tax increase.
  • · Fresh Food Business GMV grew 90% YoY, with ARR crossing ₹300 Cr and kitchen footprint expanded to 75 cloud kitchens across 5 cities.
  • · Digital-first & Organic portfolio (Yogabar, 24 Mantra, Prasuma, Meatigo, Mother Sparsh) clocked ARR of approx. ₹1500 Cr.
  • · Paper Segment PBIT margin expanded 200 bps YoY.
  • · FMCG Segment EBITDA margin improved 55 bps YoY (ex-Sresta).
  • · Atta performance was tempered by transient factors including heat waves, LPG shortage and benign wheat prices.
  • · Indian Leaf Tobacco Business was impacted by lower domestic demand and subdued global offtake.
  • · The company noted significant deficit in monsoon and lower Kharif sowing levels as key watch-outs.
Maruti Suzuki India Limited Board Meeting mixed materiality 8/10

31-07-2026

Maruti Suzuki India Limited reported standalone profit of ₹33,521 Cr for Q1 FY26 (quarter ended June 30, 2026), down 10.8% YoY from ₹37,581 Cr in Q1 FY25. Revenue from operations grew 35.9% YoY to ₹524,551 Cr, driven by a 36.4% increase in product sales. However, net profit declined sequentially from ₹35,905 Cr in Q4 FY26, and earnings per share (basic) fell to ₹106.62 from ₹119.53 in the prior-year quarter. The company also completed the amalgamation of Suzuki Motor Gujarat Private Limited effective December 1, 2025.

  • · Standalone other income fell sharply to ₹18,737 Cr in Q1 FY26 from ₹18,879 Cr in Q1 FY25, a decline of 0.8% YoY.
  • · Finance costs increased 35.7% YoY to ₹635 Cr from ₹468 Cr.
  • · The amalgamation of Suzuki Motor Gujarat Private Limited was effective December 1, 2025, with no impact on consolidated results.
  • · The company is unable to estimate the financial impact of the new End-of-Life Vehicles Rules due to lack of pricing and measurement framework.
  • · Consolidated profit for Q1 FY26 was ₹34,469 Cr, down 9.1% YoY from ₹37,924 Cr.
  • · Consolidated basic EPS fell to ₹109.63 from ₹120.62 in Q1 FY25.
Maruti Suzuki India Limited Company Update mixed materiality 9/10

31-07-2026

Maruti Suzuki India Limited reported Q1 FY2026-27 results with net sales surging 36% YoY to INR 499,591 million, driven by a 29.3% increase in total sales volume and market share gains of 2.3 percentage points to 41.2%. However, net profit declined 10.8% YoY to INR 33,521 million due to rising material costs aggravated by the war, while the Board also approved four CBG manufacturing projects with a budget of INR 5,610 million.

  • · Domestic small cars sales grew 34.1% YoY, SUVs by 44.6%, and exports by 28.6%.
  • · Network inventory level at quarter end was only about 13 days.
  • · The Board approved 4 CBG projects with a budget of INR 5,610 million; expansion will be considered based on experience.
  • · Suzuki Motor Gujarat Private Limited amalgamated with MSIL effective December 1, 2025, with appointed date April 1, 2025, leading to restated financials for comparison.
Maruti Suzuki India Limited Company Update mixed materiality 8/10

31-07-2026

Maruti Suzuki India Limited reported Q1 FY27 standalone results with net sales of ₹499,591 million, up 36.4% YoY, driven by a 29.3% increase in sales volume to 682,724 units. However, operating EBITDA declined 6.7% YoY to ₹43,111 million and PAT fell 10.8% to ₹33,521 million, as margins were compressed by adverse commodity prices and foreign exchange movements. Sequentially, net sales were nearly flat (-0.2% QoQ) while operating EBITDA dropped 30.0% due to higher material costs, inventory depletion, and seasonal employee expenses.

  • · Material cost as a percentage of net sales rose 600 bps YoY to 80.5% in Q1 FY27, the primary margin drag.
  • · Employee cost ratio improved 70 bps YoY to 4.9% of net sales.
  • · Other expenses ratio improved 170 bps YoY to 11.0% of net sales.
  • · Non-operating income fell 140 bps YoY to 3.7% of net sales.
  • · Domestic sales grew 29.5% YoY to 557,988 units; exports grew 28.6% YoY to 124,736 units.
  • · Mini segment saw explosive YoY growth of 124.1% to 43,757 units, albeit from a small base.
  • · Sales to other OEM declined 19.5% YoY to 23,181 units.
  • · Sequentially, material cost ratio worsened 380 bps QoQ to 80.5%.
  • · Depreciation increased QoQ due to capacity expansion at Kharkhoda facility.
  • · Suzuki Motor Gujarat Private Limited amalgamated with MSIL effective December 1, 2025, with appointed date April 1, 2025; prior period figures restated.
Tata Steel Limited Analyst/Investor Meet neutral materiality 1/10

31-07-2026

Tata Steel Limited has announced the availability of the audio-video recording of its 1QFY2027 Earnings Discussion, held on July 31, 2026, following the approval of financial results for the quarter ended June 30, 2026 by the Board on July 30, 2026. The filing is a procedural disclosure under SEBI LODR regulations and does not contain any financial figures or performance data.

  • · The audio-video recording is available at: https://www.tatasteel.com/investors/financial-performance/analyst-call-recording/
  • · The filing was made under Regulation 30 read with Para A of Part A of Schedule III of SEBI LODR Regulations, 2015
Sun Pharmaceutical Industries Limited Corporate Governance neutral materiality 1/10

31-07-2026

Sun Pharmaceutical Industries Limited held a Board Meeting on July 31, 2026, which commenced at 10:50 AM, was adjourned for a break, and concluded at 3:40 PM. The filing is a routine disclosure of the meeting's conclusion and does not contain any financial results, business updates, or material decisions.

HCL Technologies Limited Market Notice neutral materiality 3/10

31-07-2026

HCL Technologies announced the retirement of Ms. Nishi Vasudeva as an Independent Director effective July 31, 2026, upon completion of her second term. She also ceased to be Chairperson of the Stakeholders’ Relationship Committee and a member of the Audit, Risk Management, and Nomination & Remuneration Committees. The company expressed appreciation for her contributions.

  • · Ms. Vasudeva's second term as Independent Director concluded on July 31, 2026.
  • · She ceased to be Chairperson of the Stakeholders’ Relationship Committee and Member of Audit Committee, Risk Management Committee, and Nomination & Remuneration Committee.
  • · The filing was made under Regulation 30 of SEBI Listing Regulations.
  • · No new appointments were announced as part of this filing.
State Bank of India Market Notice neutral materiality 3/10

31-07-2026

State Bank of India announced the superannuation of two senior executives, including Deputy Managing Director & Chief Credit Officer Ashok Kumar Sharma and CFO Kameshwar Rao Kodavanti, effective July 31, 2026. New responsibilities have been assigned to Satyendra Kumar Singh as Deputy Managing Director & Chief Credit Officer and Varinder Khanna as Deputy Managing Director (CCG-II), while Sunil Ramgopal Agrawal will take over as CFO from August 1, 2026. The changes are routine succession events with no financial impact disclosed.

  • · The superannuation of Ashok Kumar Sharma and Kameshwar Rao Kodavanti is effective July 31, 2026.
  • · Satyendra Kumar Singh has been entrusted with the role of Deputy Managing Director & Chief Credit Officer and Chief Sustainability Officer.
  • · Varinder Khanna has been appointed as Deputy Managing Director (CCG-II) Commercial Client Group.
  • · Sunil Ramgopal Agrawal will assume the role of Chief Financial Officer and Key Managerial Personnel from August 1, 2026.
Bharat Electronics Limited Market Notice positive materiality 6/10

31-07-2026

Bharat Electronics Limited (BEL) has announced receipt of additional orders worth Rs.847 Crore since its last disclosure on July 13, 2026. The orders span electro optics, security operation centre, seekers, components, spares, and services. No comparative prior-period data or performance trends are provided in this filing.

  • · The orders were secured since the last disclosure on July 13, 2026.
  • · Major order categories include electro optics, security operation centre, seekers, components, spares, and services.
ICICI Bank Limited Company Update neutral materiality 1/10

01-08-2026

ICICI Bank has received RBI approval for the re-appointment of Mr. Ajay Kumar Gupta as Executive Director for a further two-year term (November 27, 2026 to November 26, 2028). Shareholder approval will be sought at the upcoming Annual General Meeting on August 21, 2026. This is a routine board and regulatory update with no direct financial impact or period-over-period performance figures.

  • · RBI approval dated July 31, 2026
  • · Re-appointment effective from November 27, 2026 to November 26, 2028
  • · Shareholder vote scheduled at AGM on August 21, 2026
  • · Board had previously approved the re-appointment on January 17, 2026
Bajaj Finserv Limited Corporate Governance neutral materiality 3/10

31-07-2026

Bajaj Finserv held its 19th Annual General Meeting on July 31, 2026, via video conferencing, with 1,157 members attending. Key outcomes included the adoption of financial statements for FY2026, declaration of a dividend of ₹1.50 per equity share, and the retirement of Rajiv Bajaj as a Non-Executive Director due to increased commitments at Bajaj Auto Limited. The meeting also approved the re-appointment of statutory auditors and ratification of cost auditor remuneration, with no adverse remarks in the auditors' reports.

  • · The meeting lasted from 12:15 PM to 2:01 PM IST, including e-voting time.
  • · Rajiv Bajaj retired as Non-Executive Director due to increased professional commitments at Bajaj Auto Limited.
  • · Statutory Auditors' Report and Secretarial Auditor's Report for FY2026 contained no adverse remarks or qualifications.
  • · The company provided two-way video conferencing facility for the e-AGM via KFin Technologies.
  • · E-voting results and Scrutiniser's Report will be filed with stock exchanges within two working days.
Bajaj Finance Limited Corporate Governance neutral materiality 3/10

31-07-2026

Bajaj Finance Limited submitted voting results for its 39th Annual General Meeting (e-AGM) held on 30 July 2026, confirming that all resolutions were passed with the requisite majority. The remote e-voting period ran from 26 July to 29 July 2026, and the Scrutinizer's report has been received and placed on the company's website. No specific vote counts, resolution details, or comparative data were disclosed in this filing.

  • · The cut-off date for e-voting eligibility was 23 July 2026.
  • · Remote e-voting was open from 26 July 2026 (9:00 a.m.) to 29 July 2026 (5:00 p.m.).
  • · The e-AGM was held on 30 July 2026.
  • · The Scrutinizer's report was counter-signed by the Chairman of the meeting.
  • · The voting results and Scrutinizer's report are available on the company's website and on KFin Technologies Limited's website.
Bajaj Finance Limited Market Update neutral materiality 3/10

31-07-2026

Bajaj Finance Limited announced that at its 39th Annual General Meeting held on 30 July 2026, shareholders approved the re-appointment of Pramit Jhaveri as an Independent Director for a second term of five years (1 August 2026 to 31 July 2031). Concurrently, Rajiv Bajaj, Non-Executive Director, did not seek re-appointment due to increased commitments at Bajaj Auto Limited, effective from the close of the AGM. The changes reflect a routine board succession event with no financial impact.

  • · Pramit Jhaveri's second term as Independent Director runs from 1 August 2026 to 31 July 2031.
  • · Rajiv Bajaj stepped down due to increased professional commitments at Bajaj Auto Limited.
  • · The AGM was the 39th Annual General Meeting of the company.
Axis Bank Limited Corporate Governance positive materiality 7/10

31-07-2026

Axis Bank Limited held its 32nd Annual General Meeting on July 31, 2026, via video conferencing, where all 18 resolutions were passed with requisite majority. Key approvals included the adoption of audited financial statements for fiscal 2026, declaration of dividend, re-appointment of directors (including N.S. Vishwanathan as Independent Director and Part-time Chairman), and revisions in remuneration for MD & CEO Amitabh Chaudhry and Executive Directors. The meeting also authorized borrowing of up to ₹35,000 crore via debt securities and raising of up to ₹20,000 crore through equity or convertible instruments, along with material related party transactions with LIC, LIC Housing Finance, IDBI Bank, and Axis Max Life Insurance. All resolutions received overwhelming shareholder support, with none receiving more than 1.38% votes against.

  • · The AGM was conducted via Video Conferencing/OAVM in compliance with SEBI and MCA circulars.
  • · Remote e-voting was open from July 27, 2026 (9:00 AM IST) to July 30, 2026 (5:00 PM IST).
  • · The cut-off date for voting eligibility was July 24, 2026.
  • · E-voting during the meeting was available for 15 minutes after the meeting concluded for members who had not voted remotely.
  • · The Chairman's speech covered macro-economic environment, GPS strategy, financial performance for fiscal 2026 and Q1 fiscal 2027, digital capabilities, geographical reach, CSR/sustainability, and ESG strategy.
  • · Members raised queries on dividend payout, financial performance, future strategy, customer service, branches, ATMs, cyber security/fraud, Gen AI, CSR/ESG, fraud detection, NPAs, capex, overseas operations, employee strength/training, and stock split.
  • · All resolutions were passed with requisite majority; the highest opposition was 1.38% for Resolution 4 (re-appointment of N.S. Vishwanathan as Independent Director).
  • · No invalid votes were recorded for any resolution.
Axis Bank Limited Corporate Governance neutral materiality 5/10

31-07-2026

Axis Bank Limited held its 32nd Annual General Meeting on July 31, 2026, via video conferencing, where all 18 resolutions were passed with requisite majority. Key approvals included adoption of audited financials for FY2026, declaration of dividend, re-appointment of directors (including N.S. Vishwanathan as Independent Director and Part-time Chairman), and revisions in remuneration for MD & CEO Amitabh Chaudhry and other executive directors. The meeting also authorized borrowing up to ₹35,000 crore via debt securities and fund raising up to ₹20,000 crore through equity or convertible instruments, along with material related party transactions with LIC, LIC Housing Finance, IDBI Bank, and Axis Max Life Insurance.

  • · The AGM was conducted via Video Conferencing/Other Audio Visual Means in accordance with SEBI and MCA circulars.
  • · Remote e-voting was open from July 27, 2026 (9:00 AM IST) to July 30, 2026 (5:00 PM IST).
  • · E-voting during the meeting was available for 15 minutes after the meeting concluded for members who had not voted remotely.
  • · The Scrutinizer's report was issued by CS KVS Subramanyam of Ahalada Rao V. & Associates.
  • · All resolutions were passed with over 98% votes in favour, except Resolution 1 and 2 which had over 99.999% in favour.
  • · The meeting lasted from 10:00 AM to 12:29 PM IST.
  • · Members raised queries on dividend payout, financial performance, future strategy, customer service, branches, ATMs, cyber security/fraud, Gen AI, CSR/ESG, fraud detection, NPAs, capex, overseas business, employee strength/training, and stock split.
Sun Pharmaceutical Industries Limited Analyst/Investor Meet neutral materiality 1/10

31-07-2026

Sun Pharmaceutical Industries Limited has informed the exchanges that the audio recording of its Q1 FY27 earnings call, held on July 31, 2026, is now available on the company's website. This is a routine disclosure under Regulation 30 of the SEBI Listing Regulations and does not contain any financial results or material new information.

  • · The earnings call was held on July 31, 2026, for Q1 FY27.
  • · The audio recording is accessible via a specific URL on the company's website.
  • · The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • · The company had previously intimated the call on July 14, 2026.
Sun Pharmaceutical Industries Limited Corporate Governance mixed materiality 8/10

31-07-2026

Sun Pharmaceutical Industries held its 34th AGM on July 31, 2026, where all eight resolutions were approved by shareholders, including the reappointment of Mr. Aalok Shanghvi, appointment of Dr. Andreas Busch as Independent Director, and a final dividend of ₹5.00 per share. Chairman Dilip Shanghvi reported consolidated revenue growth of 11.9% to ₹582 billion and EBITDA growth of 16.1% to ₹177 billion, with Innovative Medicines now representing a larger share of US revenues than generics for the first time. However, the US generics business faced pricing and compliance-related pressures, and the company announced the proposed acquisition of Organon & Co., the largest transaction in its history.

  • · The AGM was held via video conferencing from 4:00 PM to 5:50 PM IST on July 31, 2026.
  • · Remote e-voting was open from July 27 to July 30, 2026, with additional e-voting during the meeting.
  • · All eight resolutions were passed with requisite majority, including the appointment of Dr. Andreas Busch as Independent Director for a five-year term (May 12, 2026 to May 11, 2031).
  • · The US generics business faced pricing and compliance-related pressures, but growth in Innovative Medicines offset these challenges.
  • · The proposed acquisition of Organon & Co. was announced after the close of FY26 and is described as the largest transaction in Sun Pharma's history.
  • · Global medicine spending is projected to reach approximately US$2.4 trillion by 2029.
  • · CSR initiatives positively impacted more than one million lives during FY26.
Larsen & Toubro Limited Company Update positive materiality 6/10

31-07-2026

Larsen & Toubro Limited announced that its subsidiary L&T Energy Hydrocarbon Onshore has signed a six-year Engineering, Procurement, and Construction (EPC) Framework Agreement with Petroleum Development Oman (PDO). Under the agreement, L&T is selected as one of four EPC contractors to participate in PDO's upcoming front-end engineering design and EPC projects, reinforcing their long-standing partnership. The agreement supports In-Country Value (ICV) development in Oman through local supplier and subcontractor opportunities.

  • · L&T has been selected as one of four EPC contractors, meaning it will compete for individual projects under the umbrella framework.
  • · The agreement scope includes both front-end engineering design (FEED) and EPC projects over six years.
  • · L&T will leverage its integrated engineering, execution capability, global expertise and innovation for PDO's projects.
  • · L&T Energy Hydrocarbon Onshore is described as 'one of India’s largest EPC businesses' delivering Lump Sum Turnkey solutions across upstream, midstream and downstream hydrocarbon sectors.
  • · PDO delivers the majority of Oman's crude oil production and natural gas supply and plays a central role in the country's energy security and economic growth.
NTPC Limited Market Notice neutral materiality 2/10

31-07-2026

NTPC Limited informed stock exchanges that Shri Ram Bhajan Malik, Executive Director (Senior Management), will cease his role due to superannuation effective 31st July 2026. This is a routine senior management change disclosure under Regulation 30 of SEBI LODR.

  • · Cessation effective date: 31st July 2026
  • · Reason: Superannuation
  • · Scrip Code: 532555, Symbol: NTPC, ISIN: INE733E01010
Bajaj Finserv Limited Corporate Governance neutral materiality 1/10

31-07-2026

The filing is a brief board meeting outcome announcement for Bajaj Finserv Ltd, stating that the board meeting commenced at 10:45 a.m. and concluded at 11:50 a.m. on July 31, 2026. No specific financial results, leadership changes, dividend recommendations, or corporate actions were disclosed in this filing. The filing is purely procedural with no material quantitative or strategic information provided.

  • · Board meeting commenced at 10:45 a.m. and concluded at 11:50 a.m. on July 31, 2026.
  • · No financial results, dividends, buybacks, or leadership changes were announced in this filing.
Bajaj Finserv Limited Market Notice neutral materiality 3/10

31-07-2026

Bajaj Finserv Limited has issued 15,11,358 equity shares of face value Re. 1 to its ESOP Trust at respective grant prices, aggregating to Rs. 196.08 crore, to meet employee stock option exercises. The issuance was approved by the Board on July 31, 2026, and is a routine primary issue under the company's Employee Stock Option Scheme. No period-over-period comparisons are available as this is a single-event disclosure.

  • · Face value of each equity share is Re. 1.
  • · The shares rank pari passu with existing equity shares.
  • · Board meeting commenced at 10:45 a.m. IST and concluded at 11:50 a.m. IST on July 31, 2026.
  • · The issuance is a primary issue (new shares) to the ESOP Trust, not a secondary transfer.
HDFC Bank Limited Market Update neutral materiality 1/10

31-07-2026

HDFC Bank has published a newspaper notice in Business Standard and its Marathi translation in Navshakti on July 31, 2026, regarding a special window for the transfer and dematerialisation of physical shares. This is a routine procedural disclosure and does not contain any financial results, strategic updates, or material business developments.

  • · The notice was published in English in Business Standard and in Marathi in Navshakti on July 31, 2026.
  • · The filing reference number is SE/2026-27/82.
  • · The bank's registered office is at HDFC Bank House, Senapati Bapat Marg, Lower Parel (West), Mumbai – 400 013.
Bajaj Finserv Limited Market Update mixed materiality 9/10

31-07-2026

Bajaj Finserv reported consolidated total income of ₹42,037 Cr for Q1 FY27, up 19% YoY from ₹35,300 Cr, and consolidated PAT of ₹6,297 Cr, up 18% YoY from ₹5,329 Cr. However, PAT attributable to owners grew only 12% to ₹3,132 Cr, and after adjusting for unrealized MTM gains, adjusted PAT growth was just 5%. The general insurance subsidiary saw PAT decline 28% to ₹478 Cr, while life insurance PAT fell sharply to ₹51 Cr from ₹171 Cr, though value of new business surged 87%.

  • · Bajaj General's combined ratio worsened to 104.7% in Q1 FY27 from 103.6% in Q1 FY26, and underwriting loss increased to ₹130 Cr from ₹116 Cr.
  • · Bajaj Life's shareholders' profit after tax dropped sharply to ₹51 Cr from ₹171 Cr YoY, despite a 35% rise in gross written premium to ₹7,399 Cr.
  • · Bajaj Finance's gross NPA improved to 0.96% from 1.03% and net NPA to 0.39% from 0.50% YoY; provisioning coverage on stage 3 assets was 60%.
  • · Bajaj General paid a dividend of ₹1,925 Cr to shareholders during the quarter, impacting its AUM which fell to ₹34,898 Cr from ₹35,199 Cr YoY.
  • · Emerging businesses (Bajaj Finserv Health, Bajaj Finserv Direct, Bajaj Asset Management, Bajaj Alternate Investment Management) reported combined losses of ₹130 Cr in Q1 FY27, as envisaged.
  • · Bajaj Asset Management recorded quarterly average AUM of ₹33,027 Cr and closing AUM of ₹31,444 Cr as on 30 June 2026.
  • · Bajaj Alternate Investment Management obtained regulatory approvals for PMS, a real estate fund, and a private equity fund.
  • · The audit report notes that four subsidiaries (reviewed by other auditors) contributed total revenues of ₹33,382.53 Cr and PAT of ₹6,252.86 Cr; fourteen unaudited subsidiaries had total revenues of ₹387.98 Cr and total loss of ₹135.33 Cr.
  • · The company's consolidated EPS (basic) for Q1 FY27 was ₹19.60, up from ₹17.47 in Q1 FY26.
Bajaj Finserv Limited Corporate Governance neutral materiality 5/10

31-07-2026

Bajaj Finserv's Board approved unaudited standalone and consolidated financial results for Q1 FY27 (quarter ended June 30, 2026) with unmodified audit opinions. The Board also approved the issue of 1,511,358 equity shares to the Bajaj Finserv ESOP Trust and granted approval to pursue re-insurance business through a new subsidiary, subject to IRDAI and other regulatory approvals. No specific financial figures or period-over-period comparisons were disclosed in this filing.

  • · The Board meeting commenced at 10:45 a.m. IST and concluded at 11:50 a.m. IST on July 31, 2026.
  • · The limited review reports on the financial results are unmodified (free from any qualifications).
  • · The equity shares to be issued to the ESOP Trust have a face value of Re. 1 each and rank pari-passu with existing equity shares.
  • · The re-insurance business will be pursued through a newly incorporated subsidiary, subject to IRDAI and other regulatory approvals.

Get daily alerts with 12 investment signals, 8 risk alerts, 9 opportunities and full AI analysis of all 31 filings

₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: BSE Sensex 30 Stocks Regulatory Filings

🇮🇳 More from India

View all →